eli lilly hims news - Search News

Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over

The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 medications.

Hosted on MSN · 22h

Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says

The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making custom-made versions.

YAHOO!Finance · 1d

Hims & Hers stock falls after Eli Lilly's weight-loss drug dropped from shortage list

Eli Lilly (LLY)'s weight loss drugs Mounjaro and Zepbound are no longer facing supply constraints, as the FDA has removed them from its shortage list — signaling the pharmaceutical giant's ability to now meet market demand.

21hon MSN

Hims & Hers Health Stock Falls as FDA Drops Eli Lilly Weight-Loss Drugs From Shortage List

Key Takeaways Hims & Hers Health shares tumbled Thursday after the Food and Drug Administration (FDA) said Eli Lilly's ...

22h

Zepbound is no longer in shortage. That could hurt off-brand weight loss drug sellers

The shortage of Eli Lilly’s (LLY) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food ...

Yahoo Finance7d

Eli Lilly and Company (LLY)

Hims & Hers Health shares tumbled Thursday after the Food and Drug Administration said Eli Lilly's popular weight-loss drugs are no longer on its list of drugs in short supply. The removal of ...

20h

Is Hims & Hers rally at risk as GLP-1 shortages ease?

Hims & Hers' (HIMS) stock drop marks the latest overhang on a company that has more than doubled in value over the past 12 ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results